Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Metformin for Treatment of ABCA4 Retinopathy

NCT04545736 is registered in ClinicalTrials.gov with National Eye Institute (NEI) as lead sponsor.

NCT NCT04545736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04545736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Metformin for Treatment of ABCA4 Retinopathy
Lead sponsor
National Eye Institute (NEI)
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
November 23, 2020
Completion date
February 2, 2029
Enrollment
55 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

abca4 retinopathy, retinal degeneration, retinal dystrophy, stargardt disease